Log in

NYSE:USNA - USANA Health Sciences Stock Price, Forecast & News

$65.10
-1.72 (-2.57 %)
(As of 01/29/2020 01:16 AM ET)
Today's Range
$64.62
Now: $65.10
$67.19
50-Day Range
$65.10
MA: $78.01
$81.54
52-Week Range
$58.30
Now: $65.10
$119.19
Volume191,639 shs
Average Volume114,663 shs
Market Capitalization$1.41 billion
P/E Ratio15.03
Dividend YieldN/A
Beta0.3
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. Read More…

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
CUSIP90328M10
Phone801-954-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.19 billion
Cash Flow$5.26 per share
Book Value$16.31 per share

Profitability

Net Income$126.22 million

Miscellaneous

Employees1,911
Market Cap$1.41 billion
Next Earnings Date2/4/2020 (Confirmed)
OptionableOptionable

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.


USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has approved a stock repurchase program on Tuesday, October 23rd 2018, which authorizes the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 5.9% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board believes its stock is undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, October, 22nd. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.87 by $0.22. The company earned $260.60 million during the quarter, compared to analyst estimates of $256.22 million. USANA Health Sciences had a net margin of 9.38% and a return on equity of 27.60%. The company's revenue was down 12.2% compared to the same quarter last year. During the same period last year, the firm posted $1.24 EPS. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for USANA Health Sciences.

How can I listen to USANA Health Sciences' earnings call?

USANA Health Sciences will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for USNA?

4 brokers have issued 12-month target prices for USANA Health Sciences' stock. Their forecasts range from $65.00 to $75.00. On average, they expect USANA Health Sciences' stock price to reach $70.00 in the next year. This suggests a possible upside of 7.5% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.

What is the consensus analysts' recommendation for USANA Health Sciences?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.

What are Wall Street analysts saying about USANA Health Sciences stock?

Here are some recent quotes from research analysts about USANA Health Sciences stock:
  • 1. According to Zacks Investment Research, "USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system. " (12/25/2019)
  • 2. Pivotal Research analysts commented, "We thought it noteworthy that the company projected average diluted shares outstanding of 22.7 million, given that 2Q diluted shares out were 23.4 million. To get to that average we expect the company will need to buy-in 1.9 million shares in the 2H. That will put average shares outstanding down 7.7% for the year. This is not so important for 2019, but it will be for next year when we see an earnings recovery of 27% at the net income line (still below 2018) but EPS growth of 38% owing to the reduced share count." (7/24/2019)

Has USANA Health Sciences been receiving favorable news coverage?

News headlines about USNA stock have trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. USANA Health Sciences earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for USANA Health Sciences.

Are investors shorting USANA Health Sciences?

USANA Health Sciences saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 1,410,000 shares, a drop of 6.6% from the December 15th total of 1,510,000 shares. Based on an average daily trading volume, of 119,900 shares, the days-to-cover ratio is presently 11.8 days. Approximately 11.7% of the company's stock are short sold. View USANA Health Sciences' Current Options Chain.

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include IBM (IBM), Gilead Sciences (GILD), Allergan (AGN), Amgen (AMGN), Intel (INTC), Ionis Pharmaceuticals (IONS), Tesla (TSLA), Western Digital (WDC), AbbVie (ABBV) and Abbott Laboratories (ABT).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 78)
  • Mr. Kevin G. Guest, CEO & Director (Age 56)
  • Mr. Jim Brown, Pres & COO (Age 50)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
  • Mr. Walter Noot, Chief Information Officer (Age 53)

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.26%), New York State Teachers Retirement System (0.06%), 6 Meridian (0.06%), Strs Ohio (0.05%), State of Alaska Department of Revenue (0.04%) and Arizona State Retirement System (0.04%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which institutional investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including Arizona State Retirement System, Dupont Capital Management Corp, Strs Ohio, Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold USANA Health Sciences company stock in the last year include Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Joshua Foukas, Myron W Wentz, Robert Auciaux and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which institutional investors are buying USANA Health Sciences stock?

USNA stock was bought by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, New York State Teachers Retirement System, FNY Investment Advisers LLC, SG Americas Securities LLC, Janney Montgomery Scott LLC and 6 Meridian. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $65.10.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $1.41 billion and generates $1.19 billion in revenue each year. The company earns $126.22 million in net income (profit) each year or $5.16 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.View Additional Information About USANA Health Sciences.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is http://www.usana.com/.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]


MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  331 (Vote Outperform)
Underperform Votes:  425 (Vote Underperform)
Total Votes:  756
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel